Filing Details

Accession Number:
0001209191-18-054431
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-05 17:35:36
Reporting Period:
2018-10-04
Accepted Time:
2018-10-05 17:35:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661567 Michael Parini 50 Northern Avenue
Boston MA 02210
Evp, Cl&Ao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-04 4,250 $122.45 43,859 No 4 M Direct
Common Stock Disposition 2018-10-04 4,250 $191.58 39,609 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-10-04 4,250 $0.00 4,250 $122.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,250 2026-01-03 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
  2. The option vests in 16 quarterly installments from 1/4/2016.